Related Experiment Video
Updated: Feb 8, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Transient inhibition of p53 homologs protects ovarian function from two distinct apoptotic pathways triggered by
So-Youn Kim1, Devi M Nair2, Megan Romero3
1Division of Reproductive Science in Medicine, Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. so-youn-kim@northwestern.edu.
Abstract:
Platinum-based chemotherapies can result in ovarian insufficiency by reducing the ovarian reserve, a reduction believed to result from apoptosis of immature oocytes via activation/phosphorylation of TAp63α by multiple kinases including CHEK2, CK1, and ABL1. Here we demonstrate that cisplatin (CDDP) induces oocyte apoptosis through a novel pathway and that temporary repression of this pathway fully preserves ovarian function in vivo. Although ABL kinase inhibitors effectively block CDDP-induced apoptosis of oocytes, oocytic ABL1, and ABL2 are dispensable for damage-induced apoptosis. Instead, CDDP activates TAp63α through the ATR > CHEK1 pathway independent of TAp63α hyper-phosphorylation, whereas X-irradiation activates the ATM > CHEK2 > TAp63α-hyper-phosphorylation pathway. Furthermore, oocyte-specific deletion of Trp73 partially protects oocytes from CDDP but not from X-ray, highlighting the fundamental differences of two pathways. Nevertheless, temporary repression of DNA damage response by a kinase inhibitor that attenuates phosphorylation of ATM, ATR, CHEK1, and CHEK2 fully preserves fertility in female mice against CDDP as well as X-ray. Our current study establishes the molecular basis and feasibility of adjuvant therapies to protect ovarian function against two distinctive gonadotoxic therapeutics, CDDP, and ionizing radiation.
Insights
Platinum chemotherapy and radiation damage oocytes via distinct pathways. Inhibiting DNA damage response kinases fully preserves ovarian function and fertility in mice against both treatments.
Area of Science:
- Reproductive biology
- Molecular oncology
- Cellular signaling
Background:
- Platinum-based chemotherapies can cause ovarian insufficiency by reducing ovarian reserve.
- Oocyte apoptosis is a key mechanism, potentially involving TAp63α phosphorylation by kinases like CHEK2, CK1, and ABL1.
Purpose of the Study:
- To elucidate the novel pathway of cisplatin-induced oocyte apoptosis.
- To investigate the feasibility of protecting ovarian function against chemotherapy and radiation.
Main Methods:
- Investigated cisplatin (CDDP) and X-irradiation effects on oocyte apoptosis in vivo.
- Utilized oocyte-specific gene deletion and kinase inhibitors targeting DNA damage response pathways (ATR/CHEK1, ATM/CHEK2).
- Assessed TAp63α activation, phosphorylation, and overall ovarian function and fertility preservation.
Main Results:
- CDDP induces oocyte apoptosis via the ATR > CHEK1 pathway, independent of TAp63α hyper-phosphorylation.
- X-irradiation activates the ATM > CHEK2 > TAp63α hyper-phosphorylation pathway.
- Temporary repression of DNA damage response kinases (ATM, ATR, CHEK1, CHEK2) fully preserves fertility in mice against both CDDP and X-ray.
Conclusions:
- Established distinct molecular pathways for CDDP and X-ray-induced oocyte apoptosis.
- Demonstrated that temporary inhibition of DNA damage response pathways is a viable strategy for preserving ovarian function against gonadotoxic agents.
- Provides a molecular basis for developing adjuvant therapies to protect fertility.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Homologous Recombination
Homologous Recombination
Feedback Inhibition
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...

